Apollo Intelligence Next-Generation Platform for Market Insights Named One of the Most Interesting AI Innovations of 2023 by PM360

December 14, 2023
Posted by: Marisa Meyers

No Comments

Greater speed to insights, and higher quality data by applying machine learning (ML) sampling intelligence derived from natural language processing (NLP) technologies.

WATERTOWN, MA December 14, 2023 — Apollo Intelligence (Apollo), a leading provider of real-time data and insights to the healthcare and life science industries, announces that its Apollo Next-Generation Platform for Market Insights was named to the 2023 Innovations Issue of PM360, a leading trade magazine for marketing decision makers in the pharmaceutical, biotech and medical device industries. Apollo was recognized in the Artificial Intelligence category.

The Apollo Intelligence Next-Generation Platform uses machine learning (ML) sampling intelligence derived from natural language processing (NLP) technologies to enable greater speed to insights and higher quality data. A significant expansion of Apollo’s underlying software that powers its market insights solutions for the life science industry, Apollo’s next-gen platform benefits both the healthcare professional (HCP) panel member, and the pharma professional who needs access to HCP insights. For the HCP community member, the platform’s redesigned member portal and experience saves time with its streamlined, targeting and matching of open research opportunities, honoraria redemption options, and self-serve settings. For pharma teams, the next-gen platform enables users to identify and target HCP respondents efficiently and seamlessly across a broader range of practice settings and other nuanced attributes.

Since deploying its new platform in Q3 2023, Apollo increased speed-to-insight by 25%, and improved its HCP members’ profiling intelligence by 34%.

This was the second year in a row that PM360 Innovations Issue has recognized Apollo’s innovative solutions, with Apollo’s brand InCrowd Essentials syndicated research solution included in the 2022 issue. Now in its 12^th year, the PM360 Innovations Issue was established as the industry’s first-ever guide to the year’s most innovative advancements. It has since become a premier resource and has expanded to include 13 categories, with 56 innovations selected by PM360’s editorial staff for inclusion in the 2023 issue out of hundreds of submissions.

“Apollo is honored to be recognized for applying AI technologies like machine learning and natural language processing to further transform and raise the bar for the entire life science market insights industry while enabling healthcare stakeholders to share their experiences and views with ease,” said Daniel S. Fitzgerald, CEO and President of Apollo. “When we improve research for clients, we honor the Apollo mission to accelerate health innovation to improve life.”

“We know the importance of innovation, which is why we expanded this issue to include the most fascinating and ground-breaking achievements being made in all areas of life sciences, healthcare, and marketing,” says Anna Stashower, CEO, Publisher, and Editor-in-Chief of PM360. “The innovations we selected are changing how our industry operates to create better ways to develop treatments, run companies, educate physicians, improve diagnosis, and much more to find better ways to serve patients ultimately.”

All of this year’s selections can be found at https://www.pm360online.com/pm360-presents-the-2023-innovators.

About PM360

PM360 is the premier, must-read magazine for marketing decision makers in the pharmaceutical, biotech, medical device, and diagnostics industries. Published monthly, PM360 is the only journal that focuses on delivering the full spectrum of practical information necessary for product managers and pharmaceutical marketing professionals to succeed in the complex and highly regulated healthcare environment.

The journal’s targeted and insightful editorial focuses on issues that directly impact critical decision making, including: Planning and implementation of cutting-edge strategies, trends, the latest technological advances, branding/marketing, advertising/promotion, patient/professional education, sales, market research, PR, and leadership. Additionally, the “360” in the title signifies the span of this critical, how-to info with personal and career insights for an enjoyable and thought-provoking read.

By providing a full circle of enriching content, PM360 is truly an indispensable tool for busy and productive marketing professionals to stay at the top of their game.

About Apollo Intelligence, LLC

Apollo’s mission is to accelerate health innovation to improve life. In 2019, Apollo launched with the acquisition of InCrowd, a pioneer of real-time, automated insights for the life science industry. In 2020, Apollo strengthened its global reach, by acquiring Survey Healthcare Global, a global market leader in first-party healthcare data collection and custom survey solutions. Apollo provides access to 2 million healthcare stakeholders worldwide—including physicians, patients, caregivers, and allied healthcare professionals. Apollo’s 250+ employees support top global pharmaceutical and healthcare brands, market research agencies, and consultancies across 13 countries in the Americas, Europe, and Asia. Apollo is a portfolio company of Frazier Healthcare Partners. For more information about Apollo, please visit our website at www.apollointelligence.net.

###

Contacts:

Kate Maul
Marketing Brand Leader for Apollo Intelligence
Kate.Maul@apollointelligence.net
617-934-1600

Mary Kae Marinac
PR Representative for Apollo Intelligence
mk@mkmarinac.com
978-685-3136